SPEAKER FACULTY

Adam Freund

Founder & Chief Executive Officer

Arda Therapeutics

Alex Barron

Principal Scientist II, Fibrosis Group

Novartis

Andrew John Whittle

Director, BD&L

Boehringer Ingelheim

Anil Karihaloo

Sr Principal Res Scientist

Novo Nordisk

Chan Whiting

Chief Scientific Officer

Deciduous Therapeutics

Christina Wenglen, 8th Antifibrotic Drug Development Summit 2024

Christina Wenglén

Head of Research

Anamar

David lagares

CEO

Zenon Biotech

Eric Campeau

Vice President Translational Research

Thryv Therapeutics

Francesco Del Galdo

Professor of Experimental Medicine

Leeds Institute of Rheumatic and Musculoskeletal Medicine

Geoffrey Teixeira

SVP, Head of Fibrosis

Alentis Therapeutics

Jack Castle

Head of Corporate Development

Ochre Bio

Jen-Chieh(Jay) Chuang

Director, Translational Biomarker Lead, Liver diseases

Takeda

Jijun Dong

Chief Scientific Officer

Salubris

Johan Raud

CSO

Vicore Pharma

Joseph Wu

Professor

Stanford University

Katie McCauley

Head of Fibrosis Research

Novartis

Kevin Hart

Associate Research Fellow, Scientific Director, Fibrosis Exploratory Biology and Drug Discovery Group

Pfizer

Lee Borthwick, COO, Fibrofind, 8th Antifibrotic Drug Development Summit 2024

Lee Borthwick

Chief Operating Officer & Director

FibroFind

Marc Hertz

President & CEO

GRI Bio

Mette Viberg ostergaard

Principal Scientist

Novo Nordisk

Mitchell Jones

Chief Medical Officer

Palisade Bio

Ole J. Kaasboell

CSO

Tribune Therapeutics

Scott Turner

CSO

Arda Therapeutics

Seulki Lee

Founder & Chief Executive Officer

D&D Pharmatech

Timothy McKinsey

Professor

University of Colorado Denver

Ulrika WARPMAN BERGLUND

CEO

Oxcia

FULL EVENT GUIDE
REGISTER
PARTNER